| Dr Kimberly C Riquelme, DO | |
|
1353 Gold Star Hwy, Groton, CT 06340 | |
| (860) 449-9947 | |
| Not Available |
| Full Name | Dr Kimberly C Riquelme |
|---|---|
| Gender | Female |
| Speciality | Psychiatry & Neurology - Child & Adolescent Psychiatry |
| Location | 1353 Gold Star Hwy, Groton, Connecticut |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1619282191 | NPI | - | NPPES |
| 54151 | Other | CT | LICENSE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084P0800X | Psychiatry & Neurology - Psychiatry | 54151 (Connecticut) | Secondary |
| 2084P0804X | Psychiatry & Neurology - Child & Adolescent Psychiatry | 54151 (Connecticut) | Primary |
| Entity Name | Windham Community Memorial Hospital, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1023191467 PECOS PAC ID: 2961309059 Enrollment ID: O20031217000231 |
News Archive
New research has shed light on the origins of a fungal infection which is one of the major causes of death from AIDS-related illnesses. The study, published today in the journal PLoS Pathogens, funded by the Wellcome Trust and the BBSRC, shows how the more virulent forms of Cryptococcus neoformans evolved and spread out of Africa and into Asia.
CEFALY Technology announced today that its received U.S. Food and Drug Administration approval of the Cefaly medical device for the preventative treatment for migraine headaches. Cefaly is the first transcutaneous electrical nerve stimulation (TENS) device specifically authorized for use prior to the onset of pain. It is expected to be available in the U.S. in early April.
It has long been known that so-called place cells in the human hippocampus are responsible for coding one's position in space.
The rising cost of using these "me-too" drugs at prices far exceeding those of time-tested competitors deserves careful scrutiny, say the authors, based at the University of British Columbia in Canada, where spending on drugs doubled between 1996 and 2003.
This webinar series is brought to you by APC Microbiome Ireland, and Atlantia Clinical Trials. Exciting times ahead as we announce this unique event, which will offer industry professionals the opportunity to gain insights not found elsewhere.
› Verified 9 days ago
| Entity Name | Northeast Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1043278351 PECOS PAC ID: 1254233836 Enrollment ID: O20040123000522 |
News Archive
New research has shed light on the origins of a fungal infection which is one of the major causes of death from AIDS-related illnesses. The study, published today in the journal PLoS Pathogens, funded by the Wellcome Trust and the BBSRC, shows how the more virulent forms of Cryptococcus neoformans evolved and spread out of Africa and into Asia.
CEFALY Technology announced today that its received U.S. Food and Drug Administration approval of the Cefaly medical device for the preventative treatment for migraine headaches. Cefaly is the first transcutaneous electrical nerve stimulation (TENS) device specifically authorized for use prior to the onset of pain. It is expected to be available in the U.S. in early April.
It has long been known that so-called place cells in the human hippocampus are responsible for coding one's position in space.
The rising cost of using these "me-too" drugs at prices far exceeding those of time-tested competitors deserves careful scrutiny, say the authors, based at the University of British Columbia in Canada, where spending on drugs doubled between 1996 and 2003.
This webinar series is brought to you by APC Microbiome Ireland, and Atlantia Clinical Trials. Exciting times ahead as we announce this unique event, which will offer industry professionals the opportunity to gain insights not found elsewhere.
› Verified 9 days ago
| Entity Name | Natchaug Hospital, Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1295811321 PECOS PAC ID: 5395648737 Enrollment ID: O20040202000008 |
News Archive
New research has shed light on the origins of a fungal infection which is one of the major causes of death from AIDS-related illnesses. The study, published today in the journal PLoS Pathogens, funded by the Wellcome Trust and the BBSRC, shows how the more virulent forms of Cryptococcus neoformans evolved and spread out of Africa and into Asia.
CEFALY Technology announced today that its received U.S. Food and Drug Administration approval of the Cefaly medical device for the preventative treatment for migraine headaches. Cefaly is the first transcutaneous electrical nerve stimulation (TENS) device specifically authorized for use prior to the onset of pain. It is expected to be available in the U.S. in early April.
It has long been known that so-called place cells in the human hippocampus are responsible for coding one's position in space.
The rising cost of using these "me-too" drugs at prices far exceeding those of time-tested competitors deserves careful scrutiny, say the authors, based at the University of British Columbia in Canada, where spending on drugs doubled between 1996 and 2003.
This webinar series is brought to you by APC Microbiome Ireland, and Atlantia Clinical Trials. Exciting times ahead as we announce this unique event, which will offer industry professionals the opportunity to gain insights not found elsewhere.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Kimberly C Riquelme, DO 1353 Gold Star Hwy, Groton, CT 06340-2739 Ph: (860) 449-9947 | Dr Kimberly C Riquelme, DO 1353 Gold Star Hwy, Groton, CT 06340 Ph: (860) 449-9947 |
News Archive
New research has shed light on the origins of a fungal infection which is one of the major causes of death from AIDS-related illnesses. The study, published today in the journal PLoS Pathogens, funded by the Wellcome Trust and the BBSRC, shows how the more virulent forms of Cryptococcus neoformans evolved and spread out of Africa and into Asia.
CEFALY Technology announced today that its received U.S. Food and Drug Administration approval of the Cefaly medical device for the preventative treatment for migraine headaches. Cefaly is the first transcutaneous electrical nerve stimulation (TENS) device specifically authorized for use prior to the onset of pain. It is expected to be available in the U.S. in early April.
It has long been known that so-called place cells in the human hippocampus are responsible for coding one's position in space.
The rising cost of using these "me-too" drugs at prices far exceeding those of time-tested competitors deserves careful scrutiny, say the authors, based at the University of British Columbia in Canada, where spending on drugs doubled between 1996 and 2003.
This webinar series is brought to you by APC Microbiome Ireland, and Atlantia Clinical Trials. Exciting times ahead as we announce this unique event, which will offer industry professionals the opportunity to gain insights not found elsewhere.
› Verified 9 days ago
Dr. Julia Jacobs, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 1 Wahoo Ave, Groton, CT 06349 Phone: 860-694-4496 | |
Dr. Douglas Charles Mcadams, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 1 Wahoo Ave, Groton, CT 06349 Phone: 860-694-4123 | |
Mark William Mittauer, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: Rte 12 Bldg 449, Groton, CT 06349 Phone: 860-694-2377 Fax: 860-694-2590 | |
Dr. Numan Gharaibeh, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 1353 Gold Star Hwy, Groton, CT 06340 Phone: 860-449-9947 | |
Robert A Grillo Jr., M.D. Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 1 Wahoo Ave, Groton, CT 06349 Phone: 860-694-4966 Fax: 860-694-3388 | |
Dr. Ismail Yahyazade, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: Route 12 Bldg 449, Naval Ambulatory Care Center Attn Professional Affairs, Groton, CT 06349 Phone: 860-694-2377 Fax: 860-694-2590 |